Paul Bamborough,
Computational Chemistry Section Head
Paul studied chemistry and completed a D.Phil. at Oxford University. After a post-doc at the University of California, San Francisco, he joined the computer-aided drug design group at Rhône-Poulenc Rorer before moving to GlaxoSmithKline in 1999. He leads a computational chemistry group and cross-functional program teams including ATAD2, but still likes to get hands-on with drug discovery targets, especially epigenetic and kinase gene families.
|
|
|
